Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

A semi-automated serum alphafetoprotein radioimmunoassay for prenatal spina bifida screening.

Vince JD, McManus TJ, Ferguson-Smith MA, Ratcliffe JG.

Br J Obstet Gynaecol. 1975 Sep;82(9):718-27.

PMID:
52372
3.

Screening for fetal neural tube defects by maternal plasma alpha-fetoprotein determination.

Clarke PC, Gordon YB, Kitau MJ, Chard T, Letchworth AT.

Br J Obstet Gynaecol. 1977 Aug;84(8):568-73.

PMID:
70213
4.

[Prenatal diagnosis of anencephaly and spina bifida. Determination of alphafetoprotein in amniotic fluid and serum in the 16th-24th gestational week].

Pedersen BN, Bang J, Lindsten J, Malmqvist E, Philip J.

Ugeskr Laeger. 1975 Jul 21;137(30):1703-6. Danish. No abstract available.

PMID:
49966
5.

[Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].

Zwahr C, Körner H, Tinschert S, Horn A, Schulze M, Voigt M.

Zentralbl Gynakol. 1988;110(3):158-67. German.

PMID:
2452529
6.

[Antenatal screening for neural tube defect by measuring alphafetoprotein in dried blood eluates (author's transl)].

Augier D, Dutau G, Petrus M, Grandjean H, Pontonnier G, Rochiccioli P.

Arch Fr Pediatr. 1981 Dec;38(10):757-60. French.

PMID:
6174100
7.

Antenatal diagnosis of neural tube defects.

Field B, Mitchell G, Kerr C.

Med J Aust. 1976 Jul 3;2(1):5-7.

PMID:
62270
8.

Alphafetoprotein and neural tube defects.

Brock JH.

J Clin Pathol Suppl (R Coll Pathol). 1976;10:157-64. No abstract available.

9.

Raised levels of maternal serum secretory acetylcholinesterase may be indicative of fetal neural tube defects in early pregnancy.

Brennand DM, Jehanli AM, Wood PJ, Smith JL.

Acta Obstet Gynecol Scand. 1998 Jan;77(1):8-13.

PMID:
9492710
10.

Letter: Screening for neural-tube defects.

Seller MJ.

Lancet. 1975 Dec 6;2(7945):1141. No abstract available.

PMID:
53618
11.

Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect.

Leighton PC, Kitau MJ, Chard T, Gordon YB, Leek AE.

Lancet. 1975 Nov 22;2(7943):1012-5.

PMID:
53498
12.

Evaluation of measurement of maternal plasma alpha-fetoprotein levels as a screening test for fetal neural tube defects.

Bond EB, Thompson W, Elwood JH, Cran GW.

Br J Obstet Gynaecol. 1977 Aug;84(8):574-7.

PMID:
70214
13.

Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.

Milunsky A, Alpert E, Kitzmiller JL, Younger MD, Neff RK.

Am J Obstet Gynecol. 1982 Apr 15;142(8):1030-2.

PMID:
6176126
14.

Effect of gestational age on screening for neural-tube defects by maternal plasma-A.F.P. measurement.

Brock DJ, Scrimgeour JB, Bolton AE, Wald N, Peto R, Barker S.

Lancet. 1975 Aug 2;2(7927):195-6.

PMID:
51957
15.

Screening for neural-tube defects.

[No authors listed]

Lancet. 1977 Jun 25;1(8026):1345-6. No abstract available.

PMID:
69060
16.
17.

[Results of an experiment in systematic prenatal screening for neural tube malformations by assay of alpha fetoproteins in dried blood samples (12,480 pregnancies)].

Augier D, Sarramon MF, Rorive C, Dutau G, Sablayrolles B, Reme JM, Rochiccioli P.

J Genet Hum. 1985 Sep;33(3-4):325-36. French.

PMID:
2414398
18.

Feasibility of serum-alpha-fetoprotein screening for fetal neural-tube defects.

Clarke M.

Lancet. 1977 May 21;1(8021):1098-9. No abstract available.

PMID:
68191
19.
20.

Letter: Screening for neural-tube defects.

Brock DJ.

Lancet. 1976 Jan 3;1(7949):46-7. No abstract available.

PMID:
54556

Supplemental Content

Support Center